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Abstract
Background: Rotavirus is the major cause of acute gastroenteritis and severe dehydrating diarrhea in young
children.
Methods: To estimate the proportion of hospital admissions for rotavirus acute gastroenteritis and identify the
circulating G and P genotypes among children under five years of age, we conducted a prospective observational
study from January to December 2008, recruiting children consecutively admitted to six hospitals in Milan and
nearby towns in northern Italy. Typing was done on stool samples by reverse transcriptase polymerase chain
reaction amplification.
Results: Of the 521 stool samples from children with acute gastroenteritis, 34.9% (95%CI, 30.8 to 39.2%) were
rotavirus-positive. Two thirds (67.6%) were under two years of age, and 13.2% were under six months. The
predominant G type was G1 (40.7%), followed by G9 (22.5%), G2 (13.2%), G3 (5.5%), G4 (3.8%) and G10 (1.6%).
Twenty-one (11.7%) mixed-G infections were identified: G1+G10 (8.8%); G1+G9 (1.6%); and G2+G10 (1.2%). Only P
[8] (67.6%) and P[4] (12.6%) types were P genotyped. The predominant single G/P combination was G1P[8] (39.7%),
followed by G9P[8] (25.3%), G2P[4] (14.3%), and G3P[8] (4.1%). All G-mixed types combined with P[8].
Conclusions: These findings show an high prevalence of rotavirus infections among children admitted to hospital
for acute gastroenteritis caused by different rotavirus strains circulating in the area studied.
Background
Rotavirus is the most common cause of acute gastroen-
teritis and the leading cause of severe dehydrating diar-
rhea in infants and young children [1]. In Europe, every
child is expected to experience episodes of gastroenteri-
tis during the first three years of life [2]. A recent study
[3] estimated that there are 3.6 million episodes of rota-
virus disease annually among the 23.6 million children
under the age of five, living in the European Union,
with 231 deaths, more than 87,000 hospitalizations and
about 700,000 primary care consultations. In the USA,
rotavirus causes an estimated 410,000 medical consulta-
tions, more than 200,000 emergency visits, and about
50,000-70,000 hospital admissions per year [4-7].
The admission rate for children with gastroenteritis
has not declined in recent years, and may even have
risen [6]. The costs of rotavirus gastroenteritis contri-
bute to a critical burden of disease in the pediatric
population [8,9]. A recent update of the global burden
of rotavirus disease put the median cost of hospital stay
in EU-25 Member States at about €1,417 [9].
Rotavirus is composed by 11 double-stranded RNA
segments surrounded by three concentric protein layers.
The outer capsid consists of VP7 (a glycoprotein) and
VP4 (a protease-sensitive protein) which carry
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A binary system of rotavirus classification has been
established to designate the neutralization specificity of
the VP7 and VP4 proteins. The VP7 serotype is known
as G and the VP4 serotype as P.
Vaccination has been suggested as a public health
strategy to prevent rotavirus infection and reduce the
burden of disease [10]. Rotavirus vaccine was recom-
mended for routine use among young children in the
USA in 2006. Currently, the World Health Organization
recommends including rotavirus vaccines in national
immunization programs in regions where the efficacy
data suggest a significant public health impact and
where appropriate infrastructure and financing resources
are available [11]. In Europe, rotavirus gastroenteritis
can now be prevented by vaccination with two vaccines
(RotaTeq®, Merck & Co. Inc, Whitehouse Station, NJ;
Rotarix®, GlaxoSmithKline Biologicals, Rixensart, Bel-
gium) licensed in 2006. In Italy, no data exists currently
about vaccination coverage.
Accurate information on the burden of rotavirus gas-
troenteritis are crucial to guide recommendations for
rotavirus vaccination [12], most epidemiological data
have been based on retrospective data. Thus, as the dis-
tribution of circulating rotavirus serotypes may vary
dynamically, prospective studies are needed to help the
health authorities in planning effective immunization
strategies, and for industry to look into the possibilities
for new up-to-date rotavirus vaccines.
The main aim of this study was to estimate the pro-
portion of rotavirus gastroenteritis and identify the dis-
tribution of circulating G and P genotype rotavirus
strains among children under five years of age living in
the metropolitan area of Milan, northern Italy, and
admitted to hospital with acute gastroenteritis. We also
examined the relationship between rotavirus genotype
and the clinical characteristics of gastroenteritis.
Methods
This prospective, multicenter, observational study was
conducted over a 12-month period, and involved six hos-
pitals in Milan and nearby towns. All children under five
years of age at admission and admitted to hospital
between 1 January and 31 December 2008 were assessed
for eligibility. Inclusion criterion was acute gastroenteritis
at enrolment. The exclusion criteria were refusal to give
written consent and a previous rotavirus vaccination.
Acute gastroenteritis was defined as three or more loose
stools per day for less than 14 days at enrolment [13].
The study was conducted in accordance with the
Declaration of Helsinki and Good Clinical Practice
guidelines. The ethics committee of each hospital
reviewed and approved the study protocol. Written
informed consent was obtained from the parents or
legal guardians at enrolment. No incentive was provided
to encourage study participation.
At enrolment, each child was visited by experienced
pediatricians (two per center), and underwent a sched-
uled medical examination including routine assessments.
The pediatricians attended a one-day training course
for standardization during t h ew e e kb e f o r es t a r t i n gt h e
study. The pediatricians also interviewed the parents or
the legal guardian to collect socio-demographic data,
medical history and clinical characteristics of the current
episode of acute gastroenteritis.
A stool sample was taken within 18 hours of admis-
sion for each child. Approximately 5 g of stool was
collected, immediately stored at -20°C, and shipped fro-
zen to the Department of Public Health-Microbiology-
Virology of the University of Milan, for analysis. Stool
samples were tested for VP6 rotavirus antigen by
immuno-chromatographic assay (Orion Diagnostica Inc.,
Espoo, Finland), according to the manufacturer’s
instructions. Viral RNA was extracted from 10% fecal
suspension using QIAamp MinElute Virus Spin (Qiagen
GmBH., Hilden Germany) according to the manufac-
turer’s instructions. The extracted viral RNA was stored
at -70°C until testing. Rotavirus RNA was detected
by hemi-nested reverse polymerase chain reaction
(RT-PCR) employing type-specific primers.
In the first round, a 881 nt fragment of the VP7
region was amplified with generic primers VP7F and
VP7R [14]. The G genotypes was subsequently deter-
mined on amplicons obtained using a pool of internal
primers specific for G1-G4 and G8-G10 rotavirus geno-
types in combination with the appropriate reverse con-
sensus primers [14]. Similarly, a 663 nt fragment of the
VP4 region was reverse transcribed and amplified using
the generic primers VP4F and VP4R, and P genotyping
was done using internal primers specific for P[4], P[6],
P[8], P[9], P[10] and P[11][15]. Lastly, the amplicons
were analyzed by electrophoresis using a 2% agarose gel
at 100 V for 60 minutes.
Diarrhea, dehydration status, body rectal temperature,
vomiting, and behavioral symptoms (i.e., irritability,
lethargy, seizure) were monitored during the hospital
stay. Diarrhea was defined in accordance with the Inter-
national Classification of Diseases (ICD)-9 code 787.91,
a n dv o m i t i n gi n c l u d e dI C D - 9c o d e s7 8 7 . 0 1a n d7 8 7 . 0 3 .
Dehydration status was recorded using the accepted
reference standard of the ‘percentage of volume lost’ cal-
culated as the difference between the rehydration weight
(post-rehydration body weight) and the acute weight
(body weight at presentation) divided by the rehydration
weight [16]. Dehydration severity was classified in accor-
dance with the European Society of Pediatric Gastroen-
terology, Hepatology and Nutrition [17] in three
categories, with body weight loss < 5%, 5-10%, >10%.
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Page 2 of 8The 20-point Ruuska-Vesikari scale [18] was used as a
further overall indicator of the severity of acute gastro-
enteritis. This scale assigns points according to duration
and intensity of diarrhea, vomiting, body temperature,
behavioral symptoms, and the treatment given. Ruuska-
Vesikari defines severity of disease as: mild, score ≤6;
moderate, score 7-10; severe, score ≥11.
Statistical analysis
The Kolmogorov-Smirnov test was used to assess nor-
mality of distribution of the variables. All variables except
age were not symmetrically distributed (P <0 . 0 5 ) .
Descriptive data for age are reported as mean and stan-
dard deviation (SD). For the other variables we report the
median (range) or number of observations (percentage).
The proportion of rotavirus gastroenteritis among all the
hospital admissions for acute gastroenteritis was calcu-
lated with the exact binomial 95% confidence interval
(CI). Comparisons of age for the rotavirus genotypes
were tested by one-way ANOVA. Comparisons of rota-
virus genotypes for non-symmetric variables were done
the Kruskal-Wallis test, followed by the non-parametric
multiple comparisons Tukey’st e s t .AP-value < 0.05 was
considered to indicate statistical significance (two-tailed
test). All statistical analyses were done using the SPSS
software, version 15.0 (SPSS Inc., Chicago, IL).
Results
A total of 638 children aged less than 5 years were
admitted with acute gastroenteritis (374 boys, 264 girls;
mean [±SD] age 1.5 ±1.3 years). Stool samples were
tested to 521 (81.7%) children: 182 (110 boys, 72 girls;
mean age 1.7 ± 1.1 years) were positive for rotavirus,
namely 34.9% (95%CI, 30.8-39.2%). There were 123
cases of rotavirus gastroenteritis in children under two
years old (67.6%): 24 (13.2%) in infants aged < 6 months;
37 (20.3%) in infants aged 6 to < 12 months; and 62
(34.1%) in infants aged 1 to < 2 years.
Severe acute gastroenteritis occurred in 126 (69.2%)
rotavirus-positive children and in 140 (41.4%) rotavirus-
negative children (P < 0.0001), with no difference
between groups in duration of hospital stay (median and
range 4 (1-10) vs. 4 (1-9) days) (P = 0.718).
Admissions for rotavirus gastroenteritis showed seaso-
nal differences (P < 0.001), with more cases in spring
(85; 46.7%) and winter (74; 40.7%) than autumn (19;
10.4%) and summer (4; 2.2%) (Figure 1). All G types
were observed both in winter and spring. The four cases
occurring in summer were one single G1, one single G9
and two G1+G10. Among cases occurring in autumn 18
were G1 (12 G1 alone, and 6 G1+G10) and one G3.
Figure 2 shows the distribution of the typed rotavirus G
genotypes over the year.
Among the 182 rotavirus-positive cases, 180 (98.9%)
were identified for G genotype and 146 (80.2%) for P
genotype (Table 1). One case (girl, age 3 months) was
neither G nor P genotyped. Single G types were
observed in 159 (87.4%) cases, mixed-G types in 21
(11.5%). G1 (74, 40.7%) was the predominant single
rotavirus G type, followed by G9 (41, 22.5%), G2 (24,
13.2%), G3 (10, 5.5%), G4 (7, 3.8%) and G10 (3, 1.6%).
Mixed-G types were identified as G1+G10 (16, 8.9%),
G1+G9 (3, 1.6%) and G2+G10 (2, 1.1%). Only P[8] (123,
67.6%) and P[4] (23, 12.6%) types were found. In 146
cases genotyped for both G and P, the predominant
combination was G1P[8] (58, 39.7%), followed by G9P
[8] (37, 25.3%) and G2P[4] (21, 14.3%). Each mixed-G
type combined with P[8].
The rotavirus gastroenteritis was rated as mild, mod-
erate or severe in 12 (6.6%), 44 (24.2%) and 126 (69.2%)
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Figure 1 Number of admissions for acute rotavirus gastroenteritis by month, in the area of Milan, northern Italy (%).
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Page 3 of 8children, respectively (Ruuska-Vesikari scale). Dehydra-
tion was < 5%, 5-10%, > 10%, in 158 (86.7%), 22 (12.2%),
and 2 (1.1%) children (one girl aged 20 months with
G3P[4], and one girl aged 47 months with G2P[4]). The
median (range) duration of diarrhea was 5 (1-11) days.
The median (range) maximum rectal temperature was
38.8°C (36.6-40.4). Vomiting occurred in 164 (90.1%)
children and 133 (73.1%) presented behavioral symp-
toms. Oral rehydration was required for 129 (70.9%)
children, intravenous rehydration for 138 (75.8%).
Table 2 summarizes the main clinical characteristics of
the rotavirus gastroenteritis, according to G and P geno-
types. Duration (median, range) of diarrhea was shorter
in G3 (3, 2-4 days) than in G1 (5, 1-10 days) and G9 (5,
2-10 days) (both P < 0.05). Duration of diarrhea was
associated with severity of gastroenteritis (Spearman
correlation coefficient, r = 0.423, P < 0.0001), percentage
of dehydration (r = 0.168, P = 0.023) and duration of
hospital stay (r = 0.554, P < 0.0001), and was longer in
younger children (r = -0.155, P < 0.0001). Maximum
rectal temperature was lower in G1+G10 than in G3
(39.6°C, 36.8-40.4) (P < 0.01). Dehydration differed
among G subtypes (P <0 . 0 0 1 )a n dw a sh i g h e ri nG 1
(1.8, 0-10%) and G3 (1.9, 0-10.9%) than G9 (0, 0-8.2%)
(P < 0.01) but the differences between G genotypes were
not significant for severity of dehydration (P > 0.287).
Similarly, the differences between G genotypes were not
significant for Ruuska-Vesikari scores (P = 0.610), num-
ber of days with vomiting (P = 0.328), or behavioral
symptoms (P = 0.417). There were no significant differ-
ences between P genotypes for any of the clinical char-
acteristics (minimum P = 0.09 for duration of diarrhea).
Mean age and sex distribution did not differ for G or P
genotypes (minimum P > 0.167). Duration of hospital
stay did not differ among G types (P = 0.250), ranging
from a median (range) of 3 (3-5) days with G10 to 7 (4-
10) days with G2+G10. Median (range) hospital stay was
respectively 5 (1-9) days and 4.5 (2-8) days in the P[8]
and P[4] subgroups, and did not differ with the P non-
typeable (36) cases (median 5, range 2-11 days) (P > 685).
Discussion
Continuous monitoring of rotavirus genotype distribu-
tion would be valuable to show up the diversity and
changes in the circulating strains that may be more
important than ever since the introduction of rotavirus
vaccination. Updating epidemiological data and extend-
ing knowledge worldwide might prove useful for design-
ing up-to-date vaccine-based prevention strategies.
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Figure 2 Number of typed rotavirus G genotypes by month, in the area of Milan, northern Italy.
Table 1 Distribution of rotavirus strains circulating
among children hospitalized with acute gastroenteritis in
the area of Milan, Northern Italy
P genotype
G genotype(s) P[8] P[4] P-negative Total
G1 58 (47.2) 0 16 (44.4) 74 (40.7)
G2 0 21 (91.3) 3 (8.3) 24 (13.2)
G3 6 (4.9) 2 (8.7) 2 (5.6) 10 (5.5)
G4 6 (4.9) 0 1 (2.8) 7 (3.8)
G9 37 (30.1) 0 4 (11.1) 41 (22.5)
G10 0 0 3 (8.3) 3 (1.6)
G1+G9 3 (2.4) 0 0 3 (1.6)
G1+G10 11 (8.9) 0 5 (13.9) 16 (8.9)
G2+G10 1 (0.8) 0 1 (2.8) 2 (1.1)
G-negative 1 (0.8) 0 1 (2.8) 2 (1.1)
Total 123 (100) 23 (100) 36 (100) 182 (100)
Data are numbers (percentage) of children
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Page 4 of 8The present study is the first to provide information
on rotavirus distribution in northern Italy. It prospec-
tively investigated the rotavirus genotype distribution
among children under five years of age living in the
metropolitan area of Milan admitted to hospital for
acute gastroenteritis. It also looked into possible rela-
tions between the clinical characteristics of disease and
the rotavirus genotype.
The findings confirmed that rotavirus is a major cause
of hospitalization for acute gastroenteritis among chil-
dren under five years of age, accounting for 34.9% of
cases. In Europe, it was estimated that in the period
2004-2005 about 10.4% to 36.0% of children aged five
years or younger and admitted with acute gastroenteritis
had disease caused by rotavirus [19]. More recently, in a
prospective study conducted in five European Union
countries (France, Germany, Italy, Spain, and the United
Kingdom) in children aged < 5 years, rotavirus
accounted for 56.2% of all hospitalized community-
acquired acute gastroenteritis cases, ranging from 33.2%
in Italy to 64.4% in France [20]. There also appears to
be a substantial burden of rotavirus hospitalization
among young children in the United States, [6,7,21,22]
with rotavirus accounting for about 18.4% of annual
hospital admissions for acute gastroenteritis among chil-
dren < 0.5 years of age [6].
In our study, most admissions for acute rotavirus gas-
troenteritis were infants, with 13.2% aged less than six
months, and two among the very youngest (less than
two months old). These figures are slightly lower than
recent European surveillance data showing that rotavirus
gastroenteritis ranged from 56.7% to 74.2% of cases of
acute gastroenteritis in infants aged 6 to 23 months, and
from 18.1% to 31.9% in infants aged < 6 months [23].
The present study found a clear seasonal pattern of
acute rotavirus gastroenteritis that peaked in winter and
early spring, with only 2.2% of cases in summer. It is
conceivable that when there is a seasonal pattern chil-
dren may become infected at later ages, because they
have not been continuously exposed to the virus [24].
Indeed, seasonality of rotavirus has been observed in dif-
ferent parts of the world; thus, it would be better for
future studies to analyse samples from a “season” rather
than a “calendar year”.
G1 was the predominant rotavirus G type, found in
51.1% of cases (40.7% alone; 10.4% in mixtures), and col-
lectively with G9 (22.5% alone; 1.6% in mixtures) and G2
(13.2% alone; 1.1% in mixtures) it accounted for more
than 90% of the rotavirus strains identified. In an extensive
review published in 2005 Santos and Hoshino [25] merged
a total of 45571 cases collected worldwide from 124 stu-
dies, and estimated that G1, G2, G3 and G4 covered about
90% of rotavirus G types. In the present study we found a
higher proportion of G9 than the 7.4% reported by De
Donno et al. [26], 2.2%-11.1% by Tcheremenskaia [27]
(except in Bulgaria where the rate of G9 was 36.6%), and
1.3-9.6% by Santos et al. [25]; however, our data compares
well with a recent European study [20] that found G9
(31.2%) was the second most prevalent circulating rota-
virus G type after G1 (40.3%). In the present study the pre-
valence of G3 was comparable with previous reports
[20,25] while circulation of G4 was lower.
Geographic and temporal differences in rotavirus gen-
otype distribution may explain at least some of these
Table 2 Clinical characteristics of rotavirus-positive children hospitalized with rotavirus acute gastroenteritis by G and
P genotypes
Genotype Ruuska-Vesikari scale Dehydration (%) Diarrhea
(no. of days)
Maximum rectal
temperature (°C)
Vomiting
(no. of days)
Behavioral
symptoms
G1 (n = 74) 13 (5-19) 1.8 (0-10) 5 (1-10) 38.7 (36.6-40) 2 (0-7) 55 (74.3)
G2 (n = 24) 13 (8-19) 0 (0-13.2) 4.5 (2-8) 38.7 (36.8-40.0) 2 (0-4) 18 (75.0)
G3 (n = 10) 13 (9-15) 1.9 (0-10.9) 3 (2-4) 39.6 (36.8-40.4) 1 (0-4) 7 (70.0)
G4 (n = 7) 14 (7-17) 0 (0-6.0) 5 (2-5) 39.0 (38.3-39.5) 1 (1-2) 5 (71.4)
G9 (n = 41) 13 (5-17) 0 (0-8.2) 5 (2-10) 38.8 (36.8-40.0) 2 (0-6) 29 (70.7)
G10 (n = 3) 14 (4-15) 2.6 (2.5-3.9) 4 (2-11) 39.2 (39.0-39.5) 2 (0-2) 2 (66.7)
G1+G9 (n = 3) 13 (11-13) 2.2 (1.1-3.5) 4 (4-5) 39.0 (38.7-39.0) 2 (1-6) 2 (66.7)
G1+G10 (n = 16) 12 (7-16) 0 (0-5.6) 5 (4-7) 38.0 (36.7-39.2) 2 (0-4) 11 (68.7)
G2+G10 (n = 2) 13.5 (11-16) 4.7 (2.6-6.8) 6 (3-9) 39.7 (39.5-39.9) 1 (1-1) 2 (100.0)
Nontypeable for G (n = 2) 11.5 (10-13) 0 (0-0) 5.5 (4-7) 37.7 (37.0-38.4) 2.5 (1-4) 1 (50.0)
P 8 (n = 123) 13 (5-19) 1.3 (0-10) 5 (1-9) 38.8 (36.7-40.0) 2 (0-6) 89 (72.4)
P 4 (n = 23) 13 (8-19) 0 (0-13.2) 4.5 (2-8) 38.7 (36.8-40.4) 2 (0-3) 16 (69.6)
Nontypeable for P (n = 36) 13 (4-19) 0.7 (0-10) 5 (2-11) 38.8 (36.6-40-0) 2 (0-7) 21 (58.3)
Whole sample 13 (4-19) 0.75 (0-13.2) 5 (1-11) 38.8 (36.6-40.4) 2 (0-7) 133 (73.1)
Median (range) or number (percentage) of children
Zuccotti et al. BMC Infectious Diseases 2010, 10:218
http://www.biomedcentral.com/1471-2334/10/218
Page 5 of 8differences, as has been pointed out in several studies
worldwide [20,25,28,29]. Recognition of G10 alone con-
firms the presence of this rotavirus genotype in Italy
and in other European countries, as reported recently
[26,27]. As a matter of fact, the prevalence (10%) of G10
mixed-G types is higher than previously reported. How-
ever it would be important to underline that 83.3% (15/
18) of patients with such genotypes were admitted to
the same hospital in a restricted period of time (Septem-
ber-December).
Epidemiological surveys showed that this genotype
may be detected in increasing proportions of infants and
young children with acute gastroenteritis in parts of
India [30], Brazil [31], Paraguay [32], and Thailand [33].
Although interspecies transmission of animal rotavirus
to humans appears to be a very rare event, the introduc-
tion of certain animal rotavirus genes into human rota-
viruses through genetic reassortment appears to be
common, as in the case of G10 [25].
Lastly, in the present study the proportion of G-mixed
types was in the found previously, ranging from about
1.6% to 12.7%.
Among P genotypes, P[8] and P[4] accounted for all P
typed cases. The predominant combinations were G1P
[8] (44.1%), G9P[8] (35.6%), G4P[8] (5.1%) and G3P[8]
(3.4%). A similar distribution was found in Europe
recently by Forster et al. [20], with G1P[8], 40.3%; G9P
[8], 31.2%; G4P[8], 13.5%; and G3P[8], 7.1%). Other
reports show G1P[8], G9P[8], G4P[8], G3P[8], and G2P
[4] as collectively responsible for more than 90% of the
rotavirus infections in Western countries, about 70% in
South America and Asia, and 50% in Africa [25]. The
importance of G9P[8] in Italy was pointed out by De
Donno et al. [26]. This type was relatively common in
South America (15%), Asia (22% in Bangladesh between
2000 and 2006 [34], 8.5% in India between 2005-2007
[35], 33.8% and 54.8% in 2001 and 2002 in Taiwan [36])
and Africa (15% in Nigeria in 2006 [37]), and possibly
less frequent in the United States where a recent ten-
year pre-vaccine surveillance (1996 to 2005) estimated
the overall rate at 3.6%, but it has now really risen to
31% in Europe [20].
Some caution is needed, however, in interpreting the
findings of the present study concerning the P genotype
because of the fairly large proportion (19.8%) of P non-
typeable samples. While this proportion is lower than in
some other studies (e.g. 38.6% in [32]), Forster et al.
[20] managed to genotype all samples. Since rotaviruses
genetically mutate (sequential point mutations, genetic
reassortment, genomic rearrangement or intragenic
recombination) [38,39], it is to be expected that some-
times today’s RT-PCR methodologies are unable to
identify all types. Unusual G/P combinations have been
described worldwide and may amount globally to about
5% of all rotavirus types. The appearance of new strains
may reflect naturally occurring reassortants among var-
ious human rotavirus genotypes but might also involve
reassortants between human and animal strains and/or
result from direct transmission from animals to humans
[40].
As regards how the rotavirus genotype was related to
the clinical features of acute gastroenteritis, we found
no statistically significant or clinically relevant differ-
ences as a whole between different G or P genotypes in
the severity of gastroenteritis, rated using the Ruuska-
Versikari scale, or the severity of dehydration, but diar-
rhea lasted about two days less with G3 than either G
alone or mixed types. However, these conclusions are
based on some very small subgroups of rotavirus types,
and this must be borne in mind, together with the wide
coefficient of variation of the clinical characteristics of
rotavirus gastroenteritis. Larger, adequately powered
longitudinal studies are needed to examine any possible
relationships between the clinical profile of rotavirus
acute gastroenteritis and G and P types.
Conclusions
In conclusion, the present study confirms the current
burden of rotavirus gastroenteritis in younger children,
especially small infants, and shows up the diversity of
rotavirus strains circulating in Milan and neighboring
areas Continuous prospective monitoring of circulating
strains may be desirable to detect any change in the dis-
tribution of rotavirus strains promptly and to assess the
effectiveness of active immunization programs.
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